Inovio Pharmaceuticals INO
NASDAQ INO
$0.84 +0.04 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Equity Income (2020 - 2022)

Updated

Inovio Pharmaceuticals (INO) reported Equity Income of -$2.17 million for FY2022, compared with -$434,387 in FY2021.

Analysis

Inovio Pharmaceuticals (INO) Equity Income (2020 - 2022) Analysis & Trends

  • According to Business Quant data, Equity Income came in at -$434,387 in FY2021 and -$4.58 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -10.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Inovio Pharmaceuticals 68.56 Mn -115.11 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 -2.17 Mn
Mar 31, 2021 -434,387.00
Dec 31, 2020 -1.92 Mn
Sep 30, 2020 -1.76 Mn
Jun 30, 2020 -901,757.00
API Access

Inovio Pharmaceuticals Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=INO&period=max&api_key=YOUR_API_KEY